Annovis Bio reports positive results in mid-stage Alzheimer’s treatment trial
29/04/2024 15:20
April 29 (Reuters) -
Annovis Bio ANVS.N said on Monday that its Alzheimer's
treatment showed significantly higher improvement in cognition
in Alzheimer's patients during a mid-stage trial.
(Reporting by Christy Santhosh; Editing by Vijay Kishore)
((Christy.Santhosh@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman